{"id":5846,"date":"2017-02-10T21:28:40","date_gmt":"2017-02-11T02:28:40","guid":{"rendered":"http:\/\/localhost:10028\/practiceareas\/treating-mesothelioma\/"},"modified":"2022-06-21T16:54:35","modified_gmt":"2022-06-21T20:54:35","slug":"mezotelyoma-tedavisi","status":"publish","type":"practiceareas","link":"https:\/\/napolilaw.lemonadestand.org\/tr\/uygulama-alanlari-2\/mezotelyoma-tedavisi\/","title":{"rendered":"Mezotelyoma Tedavisi"},"content":{"rendered":"

mezotelyoma<\/a> nadir ve ciddi bir kanser t\u00fcr\u00fcd\u00fcr. Belirli organlar\u0131 ve v\u00fccut bo\u015fluklar\u0131n\u0131 \u00e7evreleyen doku tabakas\u0131 olan mezotelyuma sald\u0131r\u0131r. Organlar\u0131 korur ve ya\u011flar, v\u00fccut i\u00e7inde hareket etmelerine, geni\u015flemelerine ve b\u00fcz\u00fclmelerine izin verir. Mezotelyoma plevray\u0131 (akci\u011ferlerin ve g\u00f6\u011fs\u00fcn astar\u0131), peritonu (kar\u0131n ve kar\u0131n organlar\u0131n\u0131n astar\u0131) veya perikard\u0131 (kalp kesesi ve g\u00f6\u011f\u00fcs bo\u015flu\u011fu) etkileyebilir. Mezotelyoma i\u00e7in bilinen bir tedavi yoktur. Tedavi, kanserin t\u00fcr\u00fc ve \u015fiddeti ile hastan\u0131n ya\u015f\u0131 ve genel sa\u011fl\u0131k durumuna g\u00f6re de\u011fi\u015fiklik g\u00f6sterebilir. Amerikan Kanser Derne\u011fi'ne g\u00f6re:<\/p>\n

Mesothelioma is a serious disease. By the time the symptoms appear the disease is often advanced. No matter what the extent of the cancer, it can be very hard to treat.<\/p>\n

The average survival times for people with mesothelioma have been between 4 and 18 months. But some people live much longer. Between 5% and 10% of people with mesothelioma live at least 5 years after their cancer is found.<\/p><\/blockquote>\n

Mezotelyoma T\u00fcrleri Tedavi Se\u00e7enekleri<\/h3>\n

The National Cancer Institute offers some helpful information about the different types of treatment available to patients diagnosed with mesothelioma. There are standard treatments, which are currently used, and there are clinical trials that are meant to improve upon current mesothelioma treatment methods or provide new methods. Depending on the outcome of a clinical trial, it may then become the new standard treatment.<\/p>\n

There are currently three primary types of standard treatment for mesothelioma:<\/p>\n

Ameliyat<\/h4>\n

Malign mezotelyoma, t\u00fcm\u00f6r\u00fcn veya t\u00fcm\u00f6rlerin konumuna ve kanserli h\u00fccrelerin v\u00fccudun di\u011fer b\u00f6lgelerine yay\u0131l\u0131p yay\u0131lmad\u0131\u011f\u0131na ba\u011fl\u0131 olarak cerrahi olarak tedavi edilebilir. A geni\u015f lokal eksizyon<\/strong> kanserli dokunun yan\u0131 s\u0131ra \u00e7evresindeki sa\u011fl\u0131kl\u0131 dokunun bir k\u0131sm\u0131n\u0131n \u00e7\u0131kar\u0131lmas\u0131n\u0131 i\u00e7erir. A\u00a0pl\u00f6rektomi ve dekortikasyon<\/strong> plevran\u0131n bir k\u0131sm\u0131n\u0131n ve akci\u011ferlerin d\u0131\u015f y\u00fczeyinin cerrahi olarak \u00e7\u0131kar\u0131lmas\u0131n\u0131 i\u00e7erir. Bir ekstraplevral pn\u00f6monektomi<\/strong> hastal\u0131kl\u0131 bir akci\u011ferin tamam\u0131n\u0131n, perikard\u0131n bir k\u0131sm\u0131n\u0131n, plevran\u0131n bir k\u0131sm\u0131n\u0131n ve diyafram\u0131n bir k\u0131sm\u0131n\u0131n cerrahi olarak \u00e7\u0131kar\u0131lmas\u0131n\u0131 i\u00e7erir. pl\u00f6redez<\/strong> plevral bo\u015flukta s\u0131v\u0131 birikmesini durdurmaya yard\u0131mc\u0131 olabilecek plevran\u0131n katmanlar\u0131 aras\u0131ndaki bo\u015flukta bir yara izi olu\u015fturmak i\u00e7in kimyasallar\u0131n veya ila\u00e7lar\u0131n kullan\u0131m\u0131n\u0131 i\u00e7erir.<\/p>\n

 <\/p>\n

Radyasyon tedavisi<\/h4>\n

Radyasyon tedavisi, kanserli h\u00fccreleri \u00f6ld\u00fcrmek veya b\u00fcy\u00fcmelerini durdurmak i\u00e7in y\u00fcksek enerjili r\u00f6ntgen \u0131\u015f\u0131nlar\u0131n\u0131n veya di\u011fer radyasyon t\u00fcrlerinin kullan\u0131lmas\u0131n\u0131 i\u00e7erir. Mezotelyoma tipine ve durumuna g\u00f6re eksternal veya internal radyasyon tedavisi kullan\u0131labilir. Harici radyasyon tedavisi<\/strong> kansere do\u011fru radyasyon g\u00f6ndermek i\u00e7in v\u00fccut d\u0131\u015f\u0131nda bir makine kullan\u0131larak uygulan\u0131r. Dahili radyasyon tedavisi<\/strong> do\u011frudan kanserin i\u00e7ine veya yak\u0131n\u0131na yerle\u015ftirilebilmesi i\u00e7in i\u011fneler, tohumlar, kateterler veya tellerle kapat\u0131lm\u0131\u015f radyoaktif bir madde kullan\u0131r.<\/p>\n

 <\/p>\n

Kemoterapi<\/h4>\n

Kemoterapi, kanserli h\u00fccreleri \u00f6ld\u00fcrmek veya b\u00fcy\u00fcmelerini durdurmak i\u00e7in a\u011f\u0131zdan al\u0131nan veya v\u00fccuda enjekte edilen ila\u00e7lar\u0131n kullan\u0131m\u0131n\u0131 i\u00e7eren bir tedavi \u015feklidir. Sistemik kemoterapi<\/strong> a\u011f\u0131zdan al\u0131nan veya bir damar veya kas i\u00e7ine enjekte edilen ila\u00e7lar\u0131 i\u00e7erir, burada kan dola\u015f\u0131m\u0131na girebilir ve v\u00fccuttaki kanser h\u00fccrelerine ula\u015fabilir. b\u00f6lgesel kemoterapi<\/strong> do\u011frudan bir organa, v\u00fccut bo\u015flu\u011funa veya beyin omurilik s\u0131v\u0131s\u0131na enjekte edilen ila\u00e7lar\u0131 i\u00e7erir ve burada esas olarak hedeflenen b\u00f6lgelerdeki kanser h\u00fccrelerini etkiler.Kombinasyon kemoterapisi<\/strong> birden fazla ilac\u0131n kullan\u0131m\u0131n\u0131 i\u00e7erir. Mezotelyoma tedavisi i\u00e7in G\u0131da ve \u0130la\u00e7 \u0130daresi (FDA) taraf\u0131ndan onaylanan baz\u0131 ila\u00e7 t\u00fcrleri aras\u0131nda Alimta, pemetreksed disodyum, sisplatin bulunur.,<\/a> Platinol and Platinol-AQ.<\/p>\n

There are also different types of clinical trials that a mesothelioma patient may decide to enter into. One type of treatment currently being studied through clinical trials is biyolojik terapi<\/strong>, burada v\u00fccut taraf\u0131ndan \u00fcretilen veya bir laboratuvarda yap\u0131lan maddeler, kanserle sava\u015fmak i\u00e7in hastan\u0131n kendi ba\u011f\u0131\u015f\u0131kl\u0131k sistemini g\u00fc\u00e7lendirmek i\u00e7in kullan\u0131l\u0131r. Bu tedavi \u015fekline imm\u00fcnoterapi de denir. Klinik deneylerde ara\u015ft\u0131r\u0131lan bir ba\u015fka mezotelyoma tedavisi, peritona (kar\u0131n ve kar\u0131n organlar\u0131n\u0131n astar\u0131) yay\u0131lm\u0131\u015f mezotelyoma tedavisi i\u00e7in bir t\u00fcr b\u00f6lgesel kemoterapidir. hipertermik intraperitoneal kemoterapi<\/strong>. Bir cerrah t\u00fcm g\u00f6r\u00fcn\u00fcr kanseri giderir ve ard\u0131ndan antikanser ila\u00e7 sol\u00fcsyonu \u0131s\u0131t\u0131l\u0131r ve kalan kanser h\u00fccrelerini \u00f6ld\u00fcrmek i\u00e7in kar\u0131n i\u00e7ine ve d\u0131\u015f\u0131na pompalan\u0131r.<\/p>\n

 <\/p>\n

Yasal Se\u00e7enekleriniz Hakk\u0131nda Bir Mezotelyoma Avukat\u0131yla Konu\u015fun<\/h3>\n

Mezotelyoma tedavisi genellikle agresiftir ve bir hastan\u0131n ya\u015fam kalitesini ve hatta g\u00fcnl\u00fck aktivitelerini ger\u00e7ekle\u015ftirme yetene\u011fini dramatik bir \u015fekilde etkileyebilecek ciddi yan etkileri olan bir hasta i\u00e7in ge\u00e7mesi son derece zor olabilir. Mezotelyoma tedavisi de pahal\u0131d\u0131r. Bir avukat tutmak ve t\u0131bbi bak\u0131m ve kay\u0131p kazan\u00e7lar i\u00e7in mali tazminat talep etmek, bir hastan\u0131n ihtiya\u00e7 duydu\u011fu bak\u0131m\u0131 almas\u0131na yard\u0131mc\u0131 olabilir ve ayr\u0131ca ailesinin mali istikrar\u0131n\u0131 sa\u011flayabilir. Bir mezotelyoma avukat\u0131yla konu\u015fun<\/a> Se\u00e7enekleriniz ve yasal haklar\u0131n\u0131z hakk\u0131nda daha fazla bilgi edinmek i\u00e7in bug\u00fcn Napoli Shkolnik PLLC'de. Yard\u0131m etmek i\u00e7in buraday\u0131z.<\/p>","protected":false},"excerpt":{"rendered":"

Mezotelyoma nadir g\u00f6r\u00fclen ve ciddi bir kanser t\u00fcr\u00fcd\u00fcr. Belirli organlar\u0131 ve v\u00fccut bo\u015fluklar\u0131n\u0131 \u00e7evreleyen doku tabakas\u0131 olan mezotelyuma sald\u0131r\u0131r. Korur ve ya\u011flar\u2026<\/p>","protected":false},"featured_media":0,"menu_order":113,"template":"","practiceareas_category":[748],"class_list":["post-5846","practiceareas","type-practiceareas","status-publish","hentry","practiceareas_category-mesothelioma"],"acf":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/practiceareas\/5846","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/practiceareas"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/types\/practiceareas"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/practiceareas\/5846\/revisions"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/media?parent=5846"}],"wp:term":[{"taxonomy":"practiceareas_category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/practiceareas_category?post=5846"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}